XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Revenue $ 2,499,766 $ 2,084,279 $ 1,767,087
Operating expenses:      
Cost of sales (exclusive of amortization of acquired intangible assets) 654,248 574,394 458,757
Research and development 425,882 393,418 385,646
Sales and marketing 727,090 846,011 861,889
General and administrative 893,204 737,304 801,262
Amortization of acquired intangible assets 92,160 97,450 95,001
Impairment of long-lived assets 621 15,969 20,210
Total operating expenses 2,793,205 2,664,546 2,622,765
Other operating income (loss) 78,427 (13,244) 0
Loss from operations (215,012) (593,511) (855,678)
Other income (expense)      
Investment income (loss), net 32,713 (19,425) 31,778
Interest expense (19,447) (19,634) (18,606)
Total other income (expense) 13,266 (39,059) 13,172
Net loss before tax (201,746) (632,570) (842,506)
Income tax benefit (expense) (2,403) 9,064 246,881
Net loss $ (204,149) $ (623,506) $ (595,625)
Net loss per share - basic (in dollars per share) $ (1.13) $ (3.54) $ (3.48)
Net loss per share - diluted (in dollars per share) $ (1.13) $ (3.54) $ (3.48)
Weighted average common shares outstanding - basic (in shares) 180,144 176,351 171,348
Weighted average common shares outstanding - diluted (in shares) 180,144 176,351 171,348